Smruthi Organics Ltd

SMRUTHIORG

Watchlist

AI Mode

‌

Market Cap

₹ 139 Cr

P/E

29.83

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

UNDER PERFORMER

Valuation

REASONABLE

Growth

SLUGGISH

Profitability

MODERATE MARGIN

Technicals

Bearish

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Smruthi Organics Limited specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs) focusing on anti-diabetic, anti-hypertension, and anti-infectives categories. They cater to a global clientele across Asia, Americas, and Africa.

The company operates two manufacturing facilities in Solapur, India, and has progressively expanded its product offerings since its incorporation in 1989.

In 2021-22, the Finished Dosage Formulations (FDF) division was fully operational, showcasing industrial advancement and scaling the company's capacity to deliver pharmaceutical products comprehensively.

Smruthi Organics has expanded its brand portfolio with the launch of 'ENERLIN' and 'SOLSITA', highlighting their commitment to innovation and market diversification.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs

Market Cap

139 Cr

Volatility

Low Risk

P/E Ratio

29.8

Industry P/E

59.2

PEG Ratio

—

P/B Ratio

2.0

52W High

169.00

52W Low

103.00

Sales CAGR

-1.28%

-1.88%

-0.79%

10Y

5.54%

Profit CAGR

-0.84%

-29.99%

-15.86%

10Y

19.38%

ROE

TTM

6.60%

5.39%

11.50%

10Y

10.47%

ROCE

TTM

10.56%

8.14%

15.95%

10Y

16.60%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
AUROLAB	252.80	161 Cr	87.81	3.76	0.00	4.47	7.31	1.55
KIMIABL	32.00	155 Cr	18.88	13.34	0.00	70.62	33.57	8.06
KREBSBIO	69.88	151 Cr	—	0.00	0.00	17.42	-19.17	-16.35
LACTOSE	113.00	145 Cr	32.09	2.32	0.00	7.24	10.49	3.28
SMRUTHIORG	122.05	139 Cr	29.83	1.97	1.23	6.60	10.56	4.69
PAR	100.42	125 Cr	12.89	1.17	0.00	9.10	12.39	7.60
TYCHE	118.90	122 Cr	12.65	0.87	2.52	6.85	9.26	6.24

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	35	30	23	40	27	29	31	38	19	32
Expenses	30	25	25	36	27	27	27	33	19	27
Operating Profit	4.62	4.43	-1.18	4.09	0.44	2.89	4.16	4.67	0.23	5.01
OPM %	13.23	14.97	-5.03	10.31	1.61	9.83	13.31	12.26	1.21	15.85
Other Income	0.01	0.00	0.00	0.06	0.00	0.01	0.00	0.08	0.09	0.01
Interest	0.33	0.39	0.32	0.37	0.41	0.44	0.51	0.52	0.46	0.66
Depreciation	1.24	1.38	1.45	1.59	1.29	1.33	1.37	1.50	1.41	1.51
Profit Before Tax	3.07	2.67	-2.95	2.19	-1.25	1.13	2.29	2.73	-1.55	2.85
Tax %	25.08	22.47	22.37	30.59	26.40	31.86	35.37	18.32	29.68	27.72
Net Profit	2.29	2.07	-2.29	1.52	-0.92	0.78	1.48	2.23	-1.10	2.06
EPS in Rs	2.00	1.81	-2.00	1.33	-0.81	0.68	1.29	1.95	-0.96	1.80

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	85	98	137	131	127	133	141	128	126	118
Expenses	69	94	121	116	98	115	131	116	114	106
Operating Profit	16	3.86	17	15	29	18	9.78	12	12	12
OPM %	18.54	3.94	12.07	11.62	22.56	13.82	6.93	9.37	9.67	10.15
Other Income	0.98	0.21	0.88	4.42	0.56	0.58	0.11	0.08	0.09	NaN
Interest	4.37	4.09	3.58	3.18	1.09	0.98	0.82	1.41	1.87	1.93
Depreciation	3.97	4.07	4.14	4.39	3.95	4.26	4.57	5.65	5.50	5.61
Profit Before Tax	2.59	-4.68	9.76	12	24	14	4.49	4.97	4.90	4.60
Tax %	38.89	31.40	29.67	30.14	28.88	24.62	8.07	27.76	27.29	26.30
Net Profit	1.58	-3.21	6.86	8.45	17	10	4.13	3.59	3.56	3.39
EPS in Rs	4.75	-3.05	5.92	7.38	11.97	9.06	3.40	3.14	3.11	4.08
Dividend Payout %	0.00	0.00	11.12	13.55	20.07	33.08	51.68	47.77	48.23	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	3.82	3.82	3.82	3.82	3.82	11	11	11	11	11
Reserves	27	28	25	33	39	49	56	57	58	60
Borrowings	31	27	29	28	16	9.90	2.82	5.70	12	17
Other Liabilities	41	26	27	37	30	21	18	32	37	23
Total Liabilities	103	85	85	101	88	92	88	106	118	112
Fixed Assets	32	30	30	30	32	31	33	37	40	45
CWIP	1.09	1.30	0.53	1.69	0.19	0.84	0.80	1.99	1.43	2.55
Investments	0.34	0.05	0.05	0.05	0.05	0.05	0.05	0.12	0.13	0.16
Other Assets	69	54	54	69	56	60	53	66	77	64
Total Assets	103	85	85	101	88	92	88	106	118	112

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	14	9.17	5.14	12	21	23	2.17	12	4.40	9.98
Cash from Investing Activity	0.16	-0.48	-3.21	-4.50	-4.52	-3.40	7.15	-10	-7.16	-11
Cash from Financing Activity	-14	-8.68	-1.77	-5.15	-17	-6.86	-12	-1.52	2.66	1.40
Net Cash Flow	-0.06	0.02	0.16	2.43	-0.58	13	-2.79	0.34	-0.11	-0.04

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	63.51%	63.58%	63.58%	63.58%	63.60%	63.84%	63.87%	63.87%	63.87%	64.73%	64.73%	64.73%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	36.49%	36.42%	36.42%	36.42%	36.40%	36.16%	36.13%	36.13%	36.13%	35.27%	35.27%	35.27%
Total Shareholders	4,770	4,824	5,107	5,605	5,752	5,877	5,869	5,972	5,959	5,905	6,047	6,356

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Mar 28, 2025	Eaga purushotham malaiah	Insider - Promoter & Director	Acquisition	110.00	0.05 Cr	4,995	0.04
Mar 26, 2025	Eaga purushotham malaiah	Insider - Promoter & Director	Acquisition	115.00	0.05 Cr	4,475	0.03
Mar 26, 2025	Eaga purushotham malaiah	Insider - Promoter & Director	Acquisition	114.00	0.01 Cr	1,190	0.01
Mar 25, 2025	Eaga purushotham malaiah	Insider - Promoter & Director	Acquisition	116.00	0.09 Cr	7,927	0.06
Mar 20, 2025	Eaga purushotham malaiah	Insider - Promoter & Director	Acquisition	121.00	0.05 Cr	4,139	0.03
Mar 18, 2025	Eaga purushotham malaiah	Insider - Promoter & Director	Acquisition	121.00	0.11 Cr	8,884	0.07
Mar 18, 2025	Eaga purushotham malaiah	Insider - Promoter & Director	Acquisition	121.00	0.11 Cr	8,884	0.07
Mar 18, 2025	Eaga purushotham malaiah	Insider - Promoter & Director	Acquisition	122.00	0.05 Cr	4,000	0.03
Mar 13, 2025	Eaga purushotham malaiah	Insider - Promoter & Director	Acquisition	117.00	0.09 Cr	7,950	0.06
Mar 13, 2025	Eaga purushotham malaiah	Insider - Promoter & Director	Acquisition	119.66	0.08 Cr	6,396	0.05

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Oscillators

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	35	30	23	40	27	29	31	38	19	32
Expenses	30	25	25	36	27	27	27	33	19	27
Operating Profit	4.62	4.43	-1.18	4.09	0.44	2.89	4.16	4.67	0.23	5.01
OPM %	13.23	14.97	-5.03	10.31	1.61	9.83	13.31	12.26	1.21	15.85
Other Income	0.01	0.00	0.00	0.06	0.00	0.01	0.00	0.08	0.09	0.01
Interest	0.33	0.39	0.32	0.37	0.41	0.44	0.51	0.52	0.46	0.66
Depreciation	1.24	1.38	1.45	1.59	1.29	1.33	1.37	1.50	1.41	1.51
Profit Before Tax	3.07	2.67	-2.95	2.19	-1.25	1.13	2.29	2.73	-1.55	2.85
Tax %	25.08	22.47	22.37	30.59	26.40	31.86	35.37	18.32	29.68	27.72
Net Profit	2.29	2.07	-2.29	1.52	-0.92	0.78	1.48	2.23	-1.10	2.06
EPS in Rs	2.00	1.81	-2.00	1.33	-0.81	0.68	1.29	1.95	-0.96	1.80

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	85	98	137	131	127	133	141	128	126	118
Expenses	69	94	121	116	98	115	131	116	114	106
Operating Profit	16	3.86	17	15	29	18	9.78	12	12	12
OPM %	18.54	3.94	12.07	11.62	22.56	13.82	6.93	9.37	9.67	10.15
Other Income	0.98	0.21	0.88	4.42	0.56	0.58	0.11	0.08	0.09	NaN
Interest	4.37	4.09	3.58	3.18	1.09	0.98	0.82	1.41	1.87	1.93
Depreciation	3.97	4.07	4.14	4.39	3.95	4.26	4.57	5.65	5.50	5.61
Profit Before Tax	2.59	-4.68	9.76	12	24	14	4.49	4.97	4.90	4.60
Tax %	38.89	31.40	29.67	30.14	28.88	24.62	8.07	27.76	27.29	26.30
Net Profit	1.58	-3.21	6.86	8.45	17	10	4.13	3.59	3.56	3.39
EPS in Rs	4.75	-3.05	5.92	7.38	11.97	9.06	3.40	3.14	3.11	4.08
Dividend Payout %	0.00	0.00	11.12	13.55	20.07	33.08	51.68	47.77	48.23	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	3.82	3.82	3.82	3.82	3.82	11	11	11	11	11
Reserves	27	28	25	33	39	49	56	57	58	60
Borrowings	31	27	29	28	16	9.90	2.82	5.70	12	17
Other Liabilities	41	26	27	37	30	21	18	32	37	23
Total Liabilities	103	85	85	101	88	92	88	106	118	112
Fixed Assets	32	30	30	30	32	31	33	37	40	45
CWIP	1.09	1.30	0.53	1.69	0.19	0.84	0.80	1.99	1.43	2.55
Investments	0.34	0.05	0.05	0.05	0.05	0.05	0.05	0.12	0.13	0.16
Other Assets	69	54	54	69	56	60	53	66	77	64
Total Assets	103	85	85	101	88	92	88	106	118	112

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	14	9.17	5.14	12	21	23	2.17	12	4.40	9.98
Cash from Investing Activity	0.16	-0.48	-3.21	-4.50	-4.52	-3.40	7.15	-10	-7.16	-11
Cash from Financing Activity	-14	-8.68	-1.77	-5.15	-17	-6.86	-12	-1.52	2.66	1.40
Net Cash Flow	-0.06	0.02	0.16	2.43	-0.58	13	-2.79	0.34	-0.11	-0.04

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
AUROLAB	252.80	161 Cr	87.81	3.76	0.00	4.47	7.31	1.55
KIMIABL	32.00	155 Cr	18.88	13.34	0.00	70.62	33.57	8.06
KREBSBIO	69.88	151 Cr	—	0.00	0.00	17.42	-19.17	-16.35
LACTOSE	113.00	145 Cr	32.09	2.32	0.00	7.24	10.49	3.28
SMRUTHIORG	122.05	139 Cr	29.83	1.97	1.23	6.60	10.56	4.69
PAR	100.42	125 Cr	12.89	1.17	0.00	9.10	12.39	7.60
TYCHE	118.90	122 Cr	12.65	0.87	2.52	6.85	9.26	6.24

Overview

Detailed Summary

The company operates two manufacturing facilities in Solapur, India, and has progressively expanded its product offerings since its incorporation in 1989.

Smruthi Organics has expanded its brand portfolio with the launch of 'ENERLIN' and 'SOLSITA', highlighting their commitment to innovation and market diversification.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs

Market Cap

139 Cr

Volatility

Low Risk

P/E Ratio

29.8

Industry P/E

59.2

PEG Ratio

—

P/B Ratio

2.0

52W High

169.00

52W Low

103.00

Sales CAGR

-1.28%

-1.88%

-0.79%

10Y

5.54%

Profit CAGR

-0.84%

-29.99%

-15.86%

10Y

19.38%

ROE

TTM

6.60%

5.39%

11.50%

10Y

10.47%

ROCE

TTM

10.56%

8.14%

15.95%

10Y

16.60%